A retrospective cohort of 97 prostatectomy patients in Jordan found clinical and pathological T staging agreed in only 61.9 ...
The statistics are sobering and undeniable — African American men develop prostate cancer at twice the rate of white men and are more likely to die from the disease. This reality makes understanding ...
Johnson & Johnson (JNJ) on Sunday said an experimental immunotherapy combination reduced a blood marker of prostate cancer ...
Oct 24 (Reuters) - Johnson & Johnson on Saturday said its experimental once-daily oral prostate cancer drug caused tumors to ...
Add Yahoo as a preferred source to see more of our stories on Google. CHICAGO — Ten years after major changes in the recommendation for prostate cancer screening, a new analysis finds a sharp increase ...
A retrospective study shows PSMA PET/MRI provides superior lymph node staging sensitivity over mpMRI in intermediate- and ...
Many get diagnosed only after their cancer has progressed beyond its earliest and most treatable stages.
Three phase 3 prostate cancer results from ESMO 2026 cover long-term survival with abiraterone in metastatic disease, Erleada before and after surgery, and an update on Truqap for PTEN-deficient ...
Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. New survey results show 80% of adults are unaware that ...
Key Stats for Johnson & Johnson StockPrice change for Johnson & Johnsonstock in the last 6 months: 16%$JNJ Stock Price as of Oct. 23: $26452-Week High: $281$JNJ Stock Price Target: $279__Now Live: ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results